IDH2 and glioblastoma: The metabolic phenotype of astrocytomas IDH-Wild type is readily distinguished from glioblastomas IDH-Wild type and oligodendrogliomas mainly because of the low levels of widespread acylcarnitines in the astrocytomas (Supplementary Table 1).